1. A five-year model to assess the early cost-effectiveness of new diagnostic tests in the early diagnosis of rheumatoid arthritis. Issue 1 (December 2016) Authors: Buisman, Leander; Luime, Jolanda; Oppe, Mark; Hazes, Johanna; Rutten-van Mölken, Maureen Journal: Arthritis research & therapy Issue: Volume 18:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Budget impact of introducing subcutaneous vedolizumab as a maintenance therapy in biologic-naïve and biologic-experienced patients with ulcerative colitis in France. (7th February 2023) Authors: Oppe, Mark; Muresan, Bogdan; Chan, Katie; Radu, Xenia; Schultz, Bob G.; Turpin, Robin S.; Nucit, Arnaud; Fenu, Elisabetta Journal: Expert review of pharmacoeconomics & outcomes research Issue: Volume 23:Number 2(2023) Page Start: 205 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cost-effectiveness of a home-based group educational programme on renal replacement therapies: a study protocol. Issue 3 (23rd March 2019) Authors: Redeker, Steef; Oppe, Mark; Visser, Martijn; Busschbach, Jan J V; Weimar, Willem; Massey, Emma; Ismail, Sohal Journal: BMJ open Issue: Volume 9:Issue 3(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cost‐Effectiveness Model for Evaluating New Diagnostic Tests in the Evaluation of Patients With Inflammatory Arthritis at Risk of Having Rheumatoid Arthritis. Issue 7 (July 2016) Authors: Luime, Jolanda J.; Buisman, Leander R.; Oppe, Mark; Hazes, Johanna M. W.; Rutten‐van Mölken, Maureen P. M. H. Journal: Arthritis care & research Issue: Volume 68:Issue 7(2016:Jul.) Page Start: 927 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Exploring the Impact of Adding a Respiratory Dimension to the EQ-5D-5L. (May 2019) Authors: Hoogendoorn, Martine; Oppe, Mark; Boland, Melinde R. S.; Goossens, Lucas M. A.; Stolk, Elly A.; Rutten–van Mölken, Maureen P. M. H. Journal: Medical decision making Issue: Volume 39:Number 4(2019) Page Start: 393 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. LEAD TIME TTO: LEADING TO BETTER HEALTH STATE VALUATIONS?. (6th March 2012) Authors: Attema, Arthur E.; Versteegh, Matthijs M.; Oppe, Mark; Brouwer, Werner B. F.; Stolk, Elly A. Journal: Health economics Issue: Volume 22:Number 4(2013:Apr.) Page Start: 376 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. PREFERRED REPORTING ITEMS FOR STUDIES MAPPING ONTO PREFERENCE-BASED OUTCOME MEASURES: THE MAPS STATEMENT. (3rd August 2015) Authors: Petrou, Stavros; Rivero-Arias, Oliver; Dakin, Helen; Longworth, Louise; Oppe, Mark; Froud, Robert; Gray, Alastair Journal: International journal of technology assessment in health care Issue: Volume 31:Number 4(2015) Page Start: 230 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement. (August 2015) Authors: Petrou, Stavros; Rivero-Arias, Oliver; Dakin, Helen; Longworth, Louise; Oppe, Mark; Froud, Robert; Gray, Alastair Journal: Medical decision making Issue: Volume 35:Number 6(2015) Page Start: NP1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗